# Travacom Post Marketing Surveillance Study

> **NCT01510132** · PHASE4 · WITHDRAWN · sponsor: **Alcon Research**

## Conditions studied

- Open-angle Glaucoma
- Ocular Hypertension

## Interventions

- **DRUG:** Travoprost/timolol fixed combination (Travacom)

## Key facts

- **NCT ID:** NCT01510132
- **Lead sponsor:** Alcon Research
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2012-01
- **Primary completion:** 2012-01
- **Final completion:** 2012-01
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2012-10-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01510132

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01510132, "Travacom Post Marketing Surveillance Study". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01510132. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*